A single course of low-dose radiation therapy may provide a safe and effective alternative treatment option for people with ...

Ataraxis AI, a frontier laboratory developing artificial intelligence (AI)–powered prognostic tools for oncology, and MEDSIR ...

Direct mailing human papillomavirus (HPV) self-testing kits to women's homes was cost-effective for those who regularly ...

GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has launched a Phase 1 clinical study titled ...

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...

Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...

Azitra Inc (($AZTR)) announced an update on their ongoing clinical study. Azitra Inc. recently updated its clinical study titled A Phase 1b/2a, ...

Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer This randomized phase Ib ...

The Company will present the reported topline results from its phase 3 SHIELD II trial at one of the world’s leading surgical ...

Parents improved their use of appropriate child car seats after remote motivational counseling and mobile-based support, ...